MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...

Kuwait Police from the capital apprehended a drug peddler in possession of 49 Lyrica pills, a psychotropic substance, during ...

MIRA Pharmaceuticals (MIRA) announced data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of ...

Ketamir-2 Demonstrates Strong Efficacy in Diabetic Neuropathy Model, with Some Subjects Achieving Complete Symptom Reversal MIAMI, FLORIDA / ACCESS Newswire / April 16, 2025 / MIRA Pharmaceuticals, ...

Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease affecting the frontal and temporal lobes that ...

MIAMI, FLORIDA / ACCESS Newswire / April 1, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing ...

Shares of Mira Pharmaceuticals gained over 19% on Wednesday, marking their best session in over a month, after the company's ...

If successful, it could represent a safer, non-addictive alternative to opioids and a more effective option than current standard treatments like pregabalin and gabapentin." Phase 1 Completion and ...

I noted some mixed Phase 2a data and a challenging market with established treatments like pregabalin and gabapentin. In November, Lexicon revealed that the Phase 2b trial completed enrollment.

While the science behind Arialief's ingredients is compelling, the accurate measure of any supplement's value lies in the ...

Pain is a complex physiological and psychological phenomenon that is subjective in nature. Pain is still one of the most challenging prevalent problems. Worldwide, the prevalence of chronic pain ...

The current strategies in neuroprotection clinical trials are based either on symptomatic treatment using antiepileptic or pain-killer drugs, such as pregabalin, lamotrigine and gabapentin ...